The Journal of Organic Chemistry
Note
Na2SO4. The resulting solution was filtered directly into a reaction
flask, to which was added triethylamine (0.2 mL, 1.43 mmol) and
benzoyl chloride (0.14 mL, 1.18 mmol). The solution was stirred for 2
h and then washed with 1.0 M HCl, water, and brine (twice). Further
purification with silica gel chromatography (ether/hexanes) provided
known cyclopropylamide 13.18
vacuo. Silica gel column chromatography (2:1 hexanes/ethyl acetate)
provided a colorless solid (0.228 g, 91%). Mp: 80−81 °C. H NMR
1
(CDCl3, 300 MHz) δ: 0.97−1.03 (m, 1H), 1.08−1.14 (m, 1H), 1.44−
1.53 (m, 1H), 1.82−1.88 (m, 1H), 2.52 (dd, J = 5.2, 9.7 Hz, 1H), 3.36
(s, 1H), 7.11−7.14 (m, 2H), 7.18 (d, J = 7.3 Hz, 1H), 7.20−7.28 (m,
1H), 7.30−7.38 (m, 4H), 7.66 (d, J = 7.6 Hz, 2H), 8.73 (s, 1H). 13C
NMR (CDCl3, 75 MHz) δ: 15.8, 19.5, 23.1, 41.9, 120.3, 124.3, 125.8,
125.9, 128.5, 129.0, 138.3, 142.4, 171.1. Low-resolution MS (EI) m/z:
251 (M+), 193, 160, 117, 93, 91, 77. HRMS (EI) m/z: calcd for
C17H17NO, 251.13102; found, 251.13120.
Amide 13 (0.1 g, 0.42 mmol) was suspended in 1 mL of anhydrous
benzene, to which was added CF3SO3H (1.0 mL, 1.9 mmol). The
mixture was stirred at 25 °C for 4−6 h, after which the solution was
poured over several grams of ice. Chloroform (30 mL) was poured
into the mixture, and the aqueous phase was made basic (pH paper)
by slow addition of 10 M NaOH. Extraction and separation of the
organic phase was followed by a second chloroform extraction (30
mL) of the aqueous phase. The combined chloroform extracts were
washed with H2O and then brine (twice). Following a drying step
(Na2SO4), filtration, removal of solvent, and silica gel chromatography
(ether/hexanes), compound 1619 was isolated (0.114 g, 0.36 mmol) as
a light-yellow solid. Mp: 163−164 °C. 1H NMR (CDCl3, 500 MHz) δ:
1.27 (d, J = 6.5 Hz, 3H), 4.03 (d, J = 9.4 Hz, 1H), 5.07−5.13 (m, 1H),
7.18−7.25 (m, 2H), 7.31−7.39 (m, 8H), 7.45 (tt, J = 1.2, 7.4 Hz, 1H),
7.48−7.53 (m, 3H), 7.62 (tt, J = 1.8, 7.4 Hz, 1H)7.83−7.84 (m, 1H).
13C NMR (CDCl3, 125 MHz) δ: 20.4, 48.0, 58.1, 126.6, 126.8, 128.3,
128.5, 128.7, 130.1, 131.2, 132.4, 135.0, 137.6, 141.7, 142.1, 166.9.
Low-resolution MS (EI) m/z: 315 (M+), 194, 167, 165, 148, 105.
HRMS (EI) m/z: calcd for C22H21NO, 315.16232; found, 315.16253.
N-(3,3-Diphenylpropyl)benzamide (20). trans-2-Phenylcyclo-
propane-1-carbonyl chloride (0.2 g, 1.1 mmol) was dissolved in
anhydrous dichloromethane (10 mL), and the solution was cooled in
an ice bath. To this solution, aniline (0.25 mL in 5 mL
dichloromethane) was added slowly. The mixture was stirred for 2 h
and then washed with 1.0 M HCl, water, and brine (twice). Further
purification with silica gel chromatography (ether/hexanes) provided
known cyclopropylamide 17.20
Amide 17 (0.1 g, 0.42 mmol) was suspended in 1 mL of anhydrous
benzene, and CF3SO3H (1.0 mL, 1.9 mmol) was added. The mixture
was stirred at 25 °C for 4−6 h, after which the solution was poured
over several grams of ice. Chloroform (30 mL) was poured into the
mixture, and the aqueous phase was made basic (pH paper) by slow
addition of 10 M NaOH. Extraction and separation of the organic
phase was followed by a second chloroform extraction (30 mL) of the
aqueous phase. The combined chloroform extracts were washed with
H2O and then brine (twice). Following a drying step (Na2SO4),
filtration, removal of solvent, and silica gel chromatography (ether/
hexanes), compound 20 was isolated (0.13 g, 0.41 mmol) as an oil. 1H
NMR (CDCl3, 300 MHz) δ: 2.32 (t, J = 7.9 Hz, 2H), 2.48−2.55 (m,
2H), 3.99 (t, J = 7.8 Hz, 1H), 7.18−7.41 (m, 13H), 7.64 (d, J = 7.7 Hz,
2H), 8.27 (s, 1H). 13C NMR (CDCl3, 75 MHz) δ: 31.2, 35.9, 50.6,
120.3, 124.3, 126.5, 128.0, 128.7, 129.0, 138.3, 144.3, 171.8. Low-
resolution MS (EI) m/z: 315 (M+), 178, 167, 165, 152, 135, 105, 93,
92. HRMS (EI) m/z: calcd for C22H21NO, 315.16232; found,
315.16280.
N-Phenyl-2-(2-phenylcyclopropyl)acetamide (21). (E)-4-Phe-
nylbut-3-enoic acid (0.162 g, 1.0 mmol), aniline (0.09 mL,1 mmol),
EDCI (0.23 g, 1.2 mmol), and DMAP (0.05 g, 0.4 mmol) were
dissolved in anhydrous dichloromethane (20 mL). The solution was
stirred for 12 h at 25 °C, after which it was partitioned between cold
water and CHCl3. The organic layer was separated, washed with H2O
(twice) and brine (twice), and dried over anhydrous sodium sulfate.
The crude product was isolated, and further purification by column
chromatography (hexane/ethyl acetate) gave the known amide (E)-
N,4-diphenylbut-3-enamide.21
According to a published procedure, a stirred solution of (E)-N,4-
diphenylbut-3-enamide (0.237 g, 1.0 mmol) was prepared with
anhydrous dichloromethane (15 mL), and diethylzinc (1.0 M in
hexane, 2.5 mL, 2.5 mmol) was then added at −20 °C under an argon
atmosphere. After 10 min, diiodomethane (0.25 mL, 3 mmol) was
slowly added to the mixture. Stirring was continued for 10 h. A
saturated NH4Cl solution was then added to the mixture, and the
resulting solution was extracted with ethyl acetate. The organic extract
was washed with brine, dried over Na2SO4, and then concentrated in
3-Methyl-N,4,4-triphenylbutanamide (24). Compound 21
(0.251 g, 1.0 mmol) was dissolved in benzene (3 mL), and
CF3SO3H (3 mL, 34 mmol) was added slowly with stirring. The
reaction mixture was stirred overnight at room temperature and then
poured over several grams of ice. Chloroform (ca. 30 mL) was then
added, and the aqueous layer was made basic with 10 M NaOH.
Separation of the organic phase was followed by washing with water
and then saturated brine (twice). The organic solution was dried with
Na2SO4 and then concentrated in vacuo. Further purification with
silica gel column chromatography (2:1 hexanes/ethyl acetate) yielded
1
compound 24 as a colorless oil (0.26 g, 79%). H NMR (CDCl3, 300
MHz) δ: 1.02 (d, J = 6.6 Hz, 3H), 2.04 (dd, J = 4.5 Hz, 1H), 2.49 (dd,
J = 3, 14.5 Hz, 1H), 3.02−3.13 (m, 1H), 3.58 (d, J = 11.1 Hz, 1H),
7.15−7.40 (m, 13H), 7.62 (d, J = 7.8 Hz, 2H), 8.01 (s, 1H). 13C NMR
(CDCl3, 75 MHz) δ: 18.9, 34.3, 43.5, 58.8, 120.2, 124.3, 126.3, 126.5,
128.0, 128.6, 128.8, 129.0, 138.2, 143.7, 143.8, 171.5. Low-resolution
MS (EI) m/z: 329 (M+), 194, 167, 165, 135, 115, 92, 77. HRMS (EI)
m/z: calcd for C23H23NO, 329.17797; found, 329.17821.
N,N-Diethyl-2-methyl-3,3-diphenylpropan-1-amine (26).
Compound 25 was prepared using a published procedure.22 Amine
25 (0.1 g, 0.49 mmol) was suspended in 1 mL of anhydrous benzene,
to which was added CF3SO3H (1.0 mL, 1.9 mmol). The mixture was
stirred at 25 °C for 4−6 h, after which the solution was poured over
several grams of ice. Chloroform (30 mL) was poured into the
mixture, and the aqueous phase was made basic (pH paper) by slow
addition of 10 M NaOH. Extraction and separation of the organic
phase was followed by a second chloroform extraction (30 mL) of the
aqueous phase. The combined chloroform extracts were washed with
H2O and then brine (twice). Following a drying step (Na2SO4),
filtration, removal of solvent, and silica gel chromatography (ether/
hexanes), known compound 26 was isolated (0.090 g, 0.32 mmol) as
an oil.23
1-Methyl-4-(2-phenylcyclopropylmethyl)piperazine (27).
Compound 27 was prepared using a published synthetic method23
and isolated as an oil. 1H NMR (CDCl3, 500 MHz) δ: 0.76−0.80 (m,
1H), 0.90−0.94 (m, 1H), 1.19−1.23 (m, 1H), 1.63 (pent, J = 4.9 Hz,
1H), 2.24 (s, 3H), 2.31 (q, J = 6.6 Hz, 2H), 2.37−2.42 (m, 4H), 2.50
(q, J = 6 Hz, 4H), 6.99−7.01 (m, 2H), 7.07−7.11 (m, 1H), 7.20 (t, J =
7.6 Hz, 2H). 13C NMR (CDCl3, 125 MHz) δ: 15.0, 20.7, 22.7, 46.1,
53.1, 55.1, 63.0, 125.4, 125.6, 128.3, 142.8. Low-resolution MS (EI)
m/z: 230 (M+), 229, 215, 139, 91, 70. HRMS (EI) m/z: calcd for
C15H22N2, 230.17830; found, 230.17855.
1-Methyl-4-(2-methyl-3,3-diphenylpropyl)piperazine (28).
Amine 27 (0.102 g, 0.43 mmol) was suspended in 1 mL of anhydrous
benzene, to which was added CF3SO3H (1.0 mL, 1.9 mmol). The
mixture was stirred at 25 °C for 4−6 h, after which the solution was
poured over several grams of ice. Chloroform (30 mL) was poured
into the mixture, and the aqueous phase was made basic (pH paper)
by slow addition of 10 M NaOH. Extraction and separation of the
organic phase was followed by a second chloroform extraction (30
mL) of the aqueous phase. The combined chloroform extracts were
washed with H2O and then brine (twice). Following a drying step
(Na2SO4), filtration, removal of solvent, and silica gel chromatography
(ether/hexanes), compound 28 was isolated (0.123 g, 0.0004 mmol)
as a light-brown solid. Mp: 141−142 °C. 1H NMR (CDCl3, 500 MHz)
δ: 0.95 (d, J = 6.5 Hz, 3H), 2.13 (dd, J = 3.1, 10.8 Hz, 1H), 2.28 (dd, J
= 4.4, 12.4 Hz, 1H), 2.40−2.45 (m, 3H), 2.61−2.67 (m, 8H), 3.70 (d,
J = 9.6 Hz, 1H), 7.18−7.33 (m, 9H). 13C NMR (CDCl3, 125 MHz) δ:
17.4, 34.3, 45.4, 52.6, 54.9, 56.8, 63.2, 126.1, 126.1, 128.0, 128.4, 128.5,
143.9, 144.2. Low-resolution MS (EI) m/z: 308 (M+), 252, 193, 167,
8925
dx.doi.org/10.1021/jo4016198 | J. Org. Chem. 2013, 78, 8922−8926